In vitro activity of the new oxazolidinone AZD2563 against Enterococci.

نویسندگان

  • G M Eliopoulos
  • C B Wennersten
  • R C Moellering
چکیده

The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci representing six species. All isolates, including those resistant to other antibiotic classes, were inhibited by AZD2563 at concentrations </=2 micro g/ml, except for four strains resistant to linezolid. In most cases, AZD2563 was twofold more active than linezolid against enterococci.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.

The in vitro activity of AZD2563, a novel oxazolidinone, was assessed against 595 Gram-positive cocci, comprising recent surveillance isolates and a collection of resistant (including multiresistant), epidemiologically diverse isolates. The MICs of AZD2563 for staphylococci, pneumococci and enterococci had narrow ranges, 0.25-2 mg/L, with modal MICs of 1 mg/L for staphylococci and pneumococci, ...

متن کامل

AZD2563, a new oxazolidinone: bactericidal activity and synergy studies with gentamicin and vancomycin against Staphylococci and Streptococci

P754 Citation: Clinical Microbiology and Infection Volume 8, Supplement 1, 2002 AZD2563, a new oxazolidinone: bactericidal activity and synergy studies with gentamicin and vancomycin against staphylococci and streptococci R. Jones, T. Anderegg, L. Deshpande, D. Biedenbach

متن کامل

Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.

The susceptibilities of clinical vancomycin-intermediate Staphylococcus aureus (VISA), heterogeneous VISA, and laboratory-generated linezolid-resistant S. aureus strains to the new oxazolidinone AZD2563 were assessed by agar dilution MIC determination. All clinical strains were susceptible to linezolid, and the linezolid MICs for them were equal to or twofold higher than those of AZD2563. Cross...

متن کامل

In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.

AZD2563, a novel oxazolidinone, and a selection of comparator drugs that included linezolid, erythromycin, clindamycin, quinolones, and gentamicin were tested against 384 Staphylococcus aureus (176 oxacillin-resistant S. aureus [ORSA]) and 219 coagulase-negative staphylococci (CoNS; 162 oxacillin resistant) by reference microdilution (all strains) and agar dilution (30 strains) methods. The fol...

متن کامل

Validation of commercial dry-form panels (sensititre) for the susceptibility testing of AZD2563, a new long-acting oxazolidinone

P1045 Citation: Clinical Microbiology and Infection Volume 8, Supplement 1, 2002 Validation of commercial dry-form panels (sensititre) for the susceptibility testing of AZD2563, a new long-acting oxazolidinone R. Jones, T. Anderegg, D. Biedenbach, P. Rhomberg

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Antimicrobial agents and chemotherapy

دوره 46 10  شماره 

صفحات  -

تاریخ انتشار 2002